SIREN : 821951464
CAMO MEDICAL 1 is a French company founded 9 years ago, specialized in the sector Activités des agences de travail temporaire . Based in SAINT-AVOLD (57500), this company of category ETI shows in 2023 a revenue of 1.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1 617 768 € | 2 721 807 € | 2 674 567 € | 2 355 879 € | 2 521 871 € | 1 900 767 € | 1 748 351 € | 696 843 € |
| Net income | 232 664 € | 374 573 € | 357 787 € | 316 158 € | 334 164 € | 257 647 € | 213 989 € | 70 840 € |
| EBITDA | 261 402 € | 491 212 € | 487 040 € | 435 352 € | 449 843 € | 318 225 € | 297 457 € | 98 430 € |
| Net margin | 14.4% | 13.8% | 13.4% | 13.4% | 13.3% | 13.6% | 12.2% | 10.2% |
In 2023, CAMO MEDICAL 1 achieves revenue of 1.6 M€. Over the period 2016-2023, the company shows strong growth with a CAGR (compound annual growth rate) of +12.8%. Significant drop of -41% vs 2022. After deducting consumption (0 €), gross margin stands at 1.6 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 261 k€, representing 16.2% of revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 233 k€, i.e. 14.4% of revenue. This profit can be retained or distributed to shareholders.
1 617 768 €
1 617 768 €
261 402 €
254 566 €
232 664 €
16.2%
The debt ratio (= Financial debt / Equity x 100) stands at 528%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 14%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 7.7 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 14.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
527.906%
14.259%
14.568%
7.676
2.8%
In 2023, the debt ratio of CAMO MEDICAL 1 (527.91) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
In 2023, the financial autonomy of CAMO MEDICAL 1 (14.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2023, the repayment capacity of CAMO MEDICAL 1 (7.68) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 792.62. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
792.622
0.0
In 2023, the liquidity ratio of CAMO MEDICAL 1 (792.62) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2023, the interest coverage of CAMO MEDICAL 1 (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 47 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 233 days. Excellent situation: suppliers finance 186 days of the operating cycle (retail model). Overall, WCR represents 402 days of revenue, i.e. 1.8 M€ to permanently finance. Over 2016-2023, WCR increased by +508%, requiring additional financing.
1 806 675 €
47 j
233 j
0 j
402 j
Based on 135 transactions of similar company sales (all years), the value of CAMO MEDICAL 1 is estimated at 388 403 € (range 199 560€ - 915 220€). With an EBITDA of 261 402€, the sector multiple of 2.0x is applied. The price/revenue ratio is 0.08x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 135 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare CAMO MEDICAL 1 with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des agences de travail temporaire
The revenue of CAMO MEDICAL 1 in 2023 is 1.6 M€.
Yes, CAMO MEDICAL 1 generated a net profit of 233 k€ in 2023.
The headquarters of CAMO MEDICAL 1 is located in SAINT-AVOLD (57500), in the department Moselle.
The tax return of CAMO MEDICAL 1 is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
CAMO MEDICAL 1 operates in the sector Activités des agences de travail temporaire (NAF code 78.20Z). See the 'Sector positioning' section above to compare the company with its competitors.